Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective June 1, 2026, Medpace Holdings, Inc. (the “ Company ”) appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations. In this role, Mr. Hansman shall perform the functions of the Company’s principal operating officer along with Susan E. Burwig, the Company’s Executive Vice President, Operations. Mr. Hansman joined the Company in April 2011 in Finance & Accounting and held various roles in Finance until July 2015. Since August 2015, Mr. Hansman has held various key leadership roles in operations including Executive Director, Vice President, and Senior Vice President overseeing study start-up, logistics, regulatory affairs, and medical writing. Prior to joining the Company, Mr. Hansman worked for Joseph Decosimo & Company, LLC as an Audit Supervisor from July 2008 to March 2011. Mr. Hansman started his career at Macy’s, Inc. where he held various auditor positions from July 2006 to June 2008. Mr. Hansman received his Bachelor of Business Administration in Accounting from Eastern Kentucky University and is a Certified Public Accountant (inactive). Mr. Hansman does not hold any public company directorships. Mr. Hansman has no family relationships with any current director, director nominee, or executive officer of the Company, and there are no transactions or proposed transactions, to which the Company is a party, or intended to be a party, in which he has, or will have, a material interest subject to disclosure under Item 404(a) of Regulation S-K. Mr. Hansman was not appointed as the Company’s Executive Vice President, Operations, pursuant to any arrangement or understanding with any other person. In connection with his appointment, Mr. Hansman will receive an annual base salary of $492,250 and will be eligible to participate in the short-term incentive compensation plan providing target cash bonus opportunities (expressed as a percentage of base salary and as described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 1, 2026) and the Company’s long-term equity incentive plan at the discretion of the Compensation Committee of the Board of Directors of the Company. Mr. Hansman and the Company have entered into the Company’s standard indemnification agreement for directors and executive officers.
MEDP Medpace Holdings, Inc. - 8-K
Accession
0001193125-26-2573875.02
Item 5.02 - Departure/Election of Directors or Certain Officers
375 words